News

Introducing the TenoTrap™ Screw System – designed to provide superior fixation for tendon repair and reconstruction.

The Tenodesis Screw System is engineered with a thread design that facilitates ease of insertion and minimizes trauma to the soft tissue during the repair process. The hybrid design also improves interlocking with the cancellous bone to minimize the incidence of pullout.

TenoTrap™ Tenodesis Screw is available in various sizes, allowing surgeons to select the appropriate option based on the depth of penetration required for a specific surgical application . We are excited to expand our soft tissue portfolio and bring this technology to the market. We look forward to seeing the positive impact it will have on patient care.

The SureFlip™ implant system is designed to assist surgeons to perform antegrade AC repair. The implant delivery system can shuttle the Constrictor® fixation button or the Constrictor® Mini adjustable buttons across bony tunnels.

The dynamic slider maintains tension in the fibers to ease passage through the bony tunnels and allows for a reliable flip during device deployment.

Watch the animation below.

For more information contact us at info@dunamismedical.com or call 877.454.2186

For Immediate Release
Contact: info@dunamismedical.com

February 14, 2020 – Dunamis Medical^® announces FDA clearance of its PunchTac^™ Anchor System for hip indications – Labral Repair/Reconstruction and gluteus medius repair. Since the product launch, Dunamis’ PunchTac^TM threaded and knotless anchors have been successfully implanted in patients.

Dunamis PunchTac^™ anchors have shown to withstand axial impaction and have the necessary torsional strength when performing implantations in high-density bone.

Dunamis Medical^® plans to begin an alpha launch April 2020 by collaborating with surgeons in multiple medical centers.

For additional information on approved indications, contraindications, warnings and potential adverse effects contact info@dunamismedical.com

For Immediate Release
Contact: info@dunamismedical.com

February 14, 2020 — Dunamis Medical® announces FDA clearance of its TensionTac™ – Knotless Anchor Technology. The novel design feature allows the surgeon to perform soft tissue repair by adjusting the tissue tension to optimize the repair. TensionTac™ Anchors will be available in different sizes and can be used to address pathologies in various anatomical locations. The anchors can be used with Dunamis coreless tape or suture technology to provide a low-profile knotless repair.

“With the ever-evolving sports medicine market and surgeon preferences, TensionTac™ Anchor System is a valuable addition to our existing suture anchor portfolio. A knotless repair is now the preferred technique when performing repairs in close proximity to the articular surface. Knot related complications have been noted when treating labral pathologies” said President and CEO Prithviraj Chavan, MD.

Dunamis Medical® plans to begin an alpha launch April 2020, by collaborating with surgeons at multiple medical centers. TensionTac™ anchor systems have been approved for various shoulder, knee, elbow, ankle and hip applications.

For additional information on approved indications, contraindications, warnings and potential adverse effects contact info@dunamismedical.com

For Immediate Release
Contact: info@dunamismedical.com

Greenville, AL – August 29, 2019 – Dunamis Medical announces FDA clearance of its Adjustable Fixation Technology for Soft Tissue Repair-Reconstruction. The Adjustable Fixation Technology is knotless, adjustable, and has a self-locking design to assist with graft tensioning. It has superior performance on cyclic loading as compared to the market leader.

Surgeons have struggled with inadequate graft tensioning which causes graft laxity, recurrent diastasis as well as loss of the repair. Devices that require knot tying are also associated with knot related complications.

Our Knotless Adjustable Fixation Technology solution uses a novel self-locking design to assist with graft tensioning after implantation. The unique locking feature can prevent graft laxity and loss of reduction. The knotless component also prevents knot tying related complications. 

“The approval of our Knotless Adjustable fixation platform technology is a result of more than 3 years of commitment to product innovation and development. Our solution provides a technological advancement and marks our entry into the flexible fixation market,” said President and CEO Prithviraj Chavan, MD. 

Dunamis Medical plans to begin an alpha launch by collaborating with surgeons in multiple medical centers. Our primary focus will be on Syndesmosis repair, AC repair, and ACL reconstruction.

View Product

For additional information on approved indications, contraindications, warnings, and potential adverse effects contact info@dunamismedical.com. 

Dunamis Medical will be exhibiting at the AAOS 2019 Annual Meeting in Las Vegas, NV.

Booth 4104

Show Dates March 13-15 2019

To learn more about Dunamis Medical products or to meet with Dr. Chavan please stop by our booth 4104.

Office: 334-371-6280
Tel: 334-239-0774

info@dunamismedical.com

View Interactive Map

Dunamis Medical will be exhibiting at the AAOS 2018 Annual Meeting in New Orleans, LA.

Booth 7120

Show Dates March 7-9

To learn more about Dunamis Medical products or to meet with Dr. Chavan please stop by our booth 7120.

Office: 334-371-6280
Tel: 334-239-0774

info@dunamismedical.com
klynch@dunamismedical.com

View Interactive Map